2 points by chncwang 6 days ago | 0 comments on HN
| Moderate positive Product · v3.7· 2026-02-26 02:44:44 0
Summary Health Information Access Advocates
ClinTrialFinder is an AI-powered clinical trial matching tool that democratizes access to research opportunities by converting complex trial data into ranked, evidence-backed recommendations in plain language. The service advocates strongly for Articles 12 (privacy), 19 (information freedom), 25 (health), and 27 (scientific participation) through its core mission of removing informational barriers to healthcare decision-making. Structurally, the platform supports these rights through free universal access, privacy protections, and algorithmic transparency, while explicitly disclaiming medical authority to preserve user autonomy and professional oversight.
Service is explicitly framed around right to health. Supports adequate standard of living and healthcare access by democratizing clinical trial information. Mission centers on health equity.
FW Ratio: 57%
Observable Facts
Service description emphasizes 'AI-powered clinical trial matching' to help users find 'trials worth considering.'
Feature removes barriers: plain language, evidence summaries, ranking by suitability.
Service is free and accessible to anyone with internet connection.
Website states: 'Find trials worth considering — ranked with evidence, not just eligibility criteria.'
Inferences
Focus on trial accessibility directly implements right to health by reducing informational barriers.
Plain-language and evidence-based ranking support informed health choices.
Free provision realizes economic right to health information.
Service explicitly advocates for freedom of information about clinical trials. Content describes transforming complex trial data into plain language, removing barriers to health information access.
FW Ratio: 57%
Observable Facts
Service description: 'We search ClinicalTrials.gov for active trials matching your condition and filter them for relevance.'
Feature: 'Plain-language explanations' for each trial recommendation.
Service removes jargon barriers by translating 'technical medical terms' into plain language.
Results show 'evidence summary for each trial' vs 'eligibility criteria only.'
Inferences
Plain-language reframing supports freedom to seek, receive, and impart health information.
Removal of jargon barriers democratizes medical knowledge historically gatekept by professionals.
Evidence summaries empower users to form independent opinions about trial suitability.
Content explicitly protects privacy by discouraging PII submission and stating that AI processing occurs with third-party services. Transparency about data flows is provided.
FW Ratio: 50%
Observable Facts
Form explicitly states: 'Do not include your name, address, email, phone number, or other personally identifiable information.'
Form includes checkbox: 'I agree to the Privacy Policy and Terms of Service, including that my text will be processed by third-party AI services.'
Privacy Policy link is visible and required for consent.
Inferences
Warnings against PII submission demonstrate proactive privacy protection.
Disclosure of third-party AI processing shows transparency in data handling.
Consent requirement respects user autonomy over private information.
Content advocates for dignity and equal access to health information through AI-powered trial matching. Preamble values (equality, non-discrimination in health) are implicitly supported by the service's design to rank trials by evidence and suitability, not just eligibility.
FW Ratio: 60%
Observable Facts
Service is described as free (price: $0).
Tool is accessible to any person with internet access; no registration or payment required on landing page.
Logo and header remain consistent across responsive design, ensuring equal access across devices.
Inferences
Free provision signals commitment to universal dignity and non-discrimination in health information access.
Removal of jargon and provision of plain-language explanations support equal participation in health decision-making.
Service supports cultural and scientific participation by democratizing access to cutting-edge clinical research. Enables lay participation in scientific advancement.
FW Ratio: 67%
Observable Facts
Service searches 'official ClinicalTrials.gov database' without restriction.
Users can access information about latest research trials in their condition.
Inferences
Democratic access to trial information enables lay participation in scientific advancement.
Service protects against abuse by designing systems that prevent harm. Disclaimer warns against autonomous medical decisions; consent required for AI processing.
FW Ratio: 50%
Observable Facts
Disclaimer: 'Always consult your doctor before enrolling in any clinical trial.'
Explicit consent required: 'I agree to the Privacy Policy and Terms of Service.'
Rate limiting observed in error handling (429 Too Many Requests).
Inferences
Physician consultation requirement prevents autonomous harm from AI recommendations.
Service supports property rights by providing equal access to valuable health information (trial rankings) without charging fees or discriminating access.
FW Ratio: 67%
Observable Facts
Service price listed as $0 USD.
No premium tiers or paywalls visible.
Inferences
Free provision democratizes access to information that could be considered a form of intellectual property or valuable asset.
Service realizes social and economic right to health by removing informational barriers to clinical trial access. Supports healthcare autonomy and informed decision-making.
FW Ratio: 67%
Observable Facts
Service is free; removes economic barrier to trial information.
Service explicitly framed as supporting informed health decisions.
Inferences
Free provision realizes social right to health information without economic discrimination.
Service respects duties to community by prioritizing patient health and informed decision-making over profit. Designed to balance individual rights with collective health good.
FW Ratio: 75%
Observable Facts
Service is free (no profit motive evident).
Privacy protections discourage PII collection.
Creator stated motivation: personal experience navigating trials (community service rather than extraction).
Inferences
Free model and privacy-first design suggest duties to community prioritized over commercial extraction.
Tool supports autonomy by providing ranked, evidence-backed recommendations that empower patients to make informed decisions about trial participation.
FW Ratio: 50%
Observable Facts
Prominent disclaimer: 'This is a decision support tool, not medical advice. Always consult your doctor before enrolling in any clinical trial.'
Users control the input (medical condition description) and receive ranked results they can independently review.
Inferences
Decision support framing respects user autonomy by providing information without coercion.
Requirement to consult physician preserves personal autonomy and professional oversight.
Service supports freedom of thought and conscience by providing unbiased, evidence-based information about treatment options without advocating for a particular choice.
FW Ratio: 67%
Observable Facts
Disclaimer states: 'This is a decision support tool, not medical advice.'
Tool provides ranked recommendations, not mandated choices.
Inferences
Decision support framing respects user conscience and medical autonomy.
Service supports peaceful assembly by providing information that empowers collective health advocacy. Enables patients to organize around shared trial opportunities.
FW Ratio: 50%
Observable Facts
Web application accessible to multiple users; no mechanism to prevent group access or sharing of results.
Inferences
Unrestricted access enables patient communities to organize around trial opportunities.
Service explicitly avoids discrimination by design. Description emphasizes algorithmic ranking by evidence, not by race, gender, or other protected characteristics.
FW Ratio: 50%
Observable Facts
Form states: 'Do not include your name, address, email, phone number, or other personally identifiable information.'
Ranking algorithm described as evidence-based and universal; applies to all conditions and patients.
Inferences
Prohibition on PII collection suggests intent to prevent discrimination based on protected characteristics.
Evidence-based ranking avoids algorithmic bias based on demographic factors.
Service implicitly supports asylum and protection by being available to anyone, regardless of immigration status (no citizenship check observed). However, this is not explicitly stated.
FW Ratio: 50%
Observable Facts
Form does not request citizenship or immigration status information.
Inferences
Absence of citizenship requirement suggests openness to all persons regardless of status.
Service indirectly supports political participation by informing citizens about health research governance (ClinicalTrials.gov is a government database). However, service does not explicitly address democratic participation.
FW Ratio: 50%
Observable Facts
Service uses official ClinicalTrials.gov data, a government-run registry.
Inferences
Reliance on government registry indirectly connects users to public health governance.
Service creator framed as having built tool 'with personal experience navigating clinical trials,' suggesting work motivated by labor/healthcare equity. However, labor rights not explicitly addressed.
FW Ratio: 50%
Observable Facts
FAQ states: 'Built by a data scientist with personal experience navigating clinical trials.'
Inferences
Creator's personal motivation suggests labor motivated by service ethic rather than pure profit.
Privacy policy linked; form explicitly discourages PII entry; states text processed by third-party AI services. Shows privacy-conscious design.
Terms of Service
—
Terms of Service linked in form but not reviewed on-domain; cannot assess content.
Identity & Mission
Mission
+0.20
Article 25 Article 29
Mission to democratize clinical trial discovery explicitly framed as health equity tool; built by founder with personal trial experience; supports right to health information access.
Editorial Code
—
No editorial guidelines or code of conduct reviewed on-domain.
Ownership
—
Independent tool built by single data scientist; no corporate parent identified on page.
Access & Distribution
Access Model
+0.15
Article 25 Article 27
Free service (price: $0); no paywall or access restrictions stated; supports universal health information access.
Ad/Tracking
—
No advertising or tracking mechanisms observed on-domain.
Accessibility
—
Responsive design evident; semantic HTML structure present; no explicit accessibility statement reviewed.
Form design actively prevents privacy violation by warning users not to submit sensitive data. Privacy Policy link provided. Consent required before submission.
Service provides unrestricted access to trial information without censorship. Evidence summaries and plain-language explanations reduce information asymmetry.
Tool treats all users equally; no discrimination in algorithmic rankings is stated or evident. Validation rules (5,000 character limit) apply uniformly.
User input directly drives the search; no predetermined options forced upon users. Explicit disclaimer states this is a decision support tool, not a directive.
build 1ad9551+j7zs · deployed 2026-03-02 09:09 UTC · evaluated 2026-03-02 10:41:39 UTC
Support HN HRCB
Each evaluation uses real API credits. HN HRCB runs on donations — no ads, no paywalls.
If you find it useful, please consider helping keep it running.